Previous reports have described the inhibitory properties of peptide Ac2-26 in models of chronic lung disease, a phenomenon accounted for by the suppression of profibrotic cytokine production including TNF-α and TGF-β [22,31]. Here, TGFB1 is linked to chronic lung disease.